This IP involves detection of early stages of dementia (known as mild cognitive impairment, including amnesiac mild cognitive impairment) using a wearable device and associated software. The device utilizes functional near infrared spectroscopy to measure cortical activity that is not detected using traditional neuroimaging approaches. This device is safe for use in populations with metal implants, is cost-effective, and can be used in ambulatory settings.